𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recombinant interferon-α2A as maintenance treatment for patients with advanced stage chronic lymphocytic leukemia responding to chemotherapy

✍ Scribed by Dr. Felicetto Ferrara; Vincenzo Rametta; Giuseppina Mele; Iolanda Antinolfi; Vincenzo Mettivier; Renato Cimino

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
387 KB
Volume
41
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alemtuzumab as treatment for residual di
Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia
✍ Susan M. O'Brien; Hagop M. Kantarjian; Deborah A. Thomas; Jorge Cortes; Francis 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to investigate the efficacy and safety of alemtuzumab, the humanized anti‐CD52 monoclonal antibody, in patients with B‐cell chronic lymphocytic leukemia and residual disease after chemotherapy. ## METHODS Forty‐one patients received alemt